Evidence map›Paper›PMID 32932951›Full record

ArticleJournal of clinical medicine2020

Autism and COVID-19: A Case Series in a Neurodevelopmental Unit.

Leslie Nollace, Cora Cravero, Alice Abbou, Brice Mazda-Walter, Alexandre Bleibtreu, Nathalie Pereirra, Myriam Sainte-Marie, David Cohen, Marianna Giannitelli

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of the COVID-19 Pandemic on Autistic Adults: a Scoping Review.Current developmental disorders reports · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Leslie NollaceDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
Cora CraveroDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.ORCID 0000-0002-8345-079X
Alice AbbouDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
Brice Mazda-WalterDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
Alexandre BleibtreuDepartment of Infectious Diseases, Pitié-Salpêtrière Hospital, APHP. Sorbonne Université, 75013 Paris, France.ORCID 0000-0001-5145-4174
Nathalie PereirraDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
Myriam Sainte-MarieDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
David CohenDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
Marianna GiannitelliDepartment of Child and Adolescent Psychiatry, Reference Centre for Rare Psychiatric Diseases, APHP. Sorbonne Université, 75013 Paris, France.
Sorbonne Université · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 has become pandemic and can impact individuals with autism as well. Here, we report a case series admitted to a neurobehavioral unit dedicated to challenging behaviors in patients with autism.

methodsWe describe 16 patients (mean age 20.8 years; range 12-43 years; 76% male) with autism hospitalized between March 2020 and mid-April 2020 for challenging behaviors, for which COVID-19 disease has been suspected and who needed both psychiatric and medical care. A close cooperation with the Infectious and Tropical Diseases Department was organized to limit viral spread and training sessions (e.g., hygiene, clinical COVID-19 monitoring, virus testing) were given to staff members.

resultsMost patients had severe autism and severe/moderate intellectual disability. Eleven patients were already in the unit when it was hit by the pandemic, and five were admitted from the community. Based on a virus search via reverse transcriptase polymerase chain reaction (RT-PCR) or serology at the 2-month follow-up, we had 11 confirmed COVID-19 cases. The main COVID-19 symptoms included benign upper respiratory infection signs (

conclusionsOrganizing a COVID+ unit for patients with autism is realistic and requires close collaboration with infectologists. We believe that this initiative should be promoted to limit both the spread of the virus and the ostracism of patients with autism and challenging behaviors.

Indexed as

autismchallenging behaviorsCOVID-19intellectual disability

Identifiers

PMID32932951
PMCPMC7564973
OpenAlexW3086009412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.